文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

认知行为疗法治疗肠易激综合征的疗效持久性和衰减:12 个月随访。

Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.

机构信息

Department of Medicine, Jacobs School of Medicine, Divisions of Behavioral Medicine and Gastroenterology, University at Buffalo, Buffalo, NY, USA.

School of Social Work, New York University, New York, NY, USA.

出版信息

Am J Gastroenterol. 2019 Feb;114(2):330-338. doi: 10.1038/s41395-018-0396-x.


DOI:10.1038/s41395-018-0396-x
PMID:30429592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6737527/
Abstract

BACKGROUND: There is a need for safe and effective IBS treatments that provide immediate and sustained improvement of IBS symptoms, particularly among more severe patients. The aim was to assess long-term clinical response of cognitive behavioral therapy (CBT) with reference to IBS education. METHODS: A total of 436 Rome III-diagnosed IBS patients (80% F, M age = 41 years) were randomized to: 4 session home-based CBT (minimal contact (MC-CBT)), 10 session clinic-based CBT (standard (S-CBT)), or 4 session IBS education (EDU). Follow-up occurred at 2 weeks and 3, 6, 9, and 12 months following treatment completion. Treatment response was based a priori on the Clinical Global Improvement Scale (global IBS symptom improvement) and IBS Symptom Severity Scale (IBS-SSS). RESULTS: Post-treatment CGI gains were generally maintained by MC-CBT patients at quarterly intervals through 12-month follow-up with negligible decay. For MC-CBT and S-CBT, 39 and 33% of respondents maintained treatment response at every follow-up assessment. The corresponding percent for EDU was 19%, which was significantly lower (p < 0.05) than for the CBT groups. On the IBS-SSS, therapeutic gains also showed a pattern of maintenance with trends towards increased efficacy over time in all conditions, with the mean unit reductions between baseline and follows-up being approximately -76 at immediate and approximately -94 at 12 months (-50 = clinically significant). CONCLUSIONS: For treatment-refractory IBS patients, home- and clinic-based CBT resulted in substantial and enduring relief of multiple IBS symptoms that generally extended to 12-month post treatment.

摘要

背景:需要安全有效的 IBS 治疗方法,以提供对 IBS 症状的即时和持续改善,特别是针对更严重的患者。本研究旨在评估认知行为疗法(CBT)与 IBS 教育相结合的长期临床疗效。

方法:共有 436 名罗马 III 诊断的 IBS 患者(80%为女性,平均年龄为 41 岁)被随机分为三组:4 次家庭为基础的认知行为疗法(最小接触(MC-CBT))、10 次诊所为基础的认知行为疗法(标准(S-CBT))或 4 次 IBS 教育(EDU)。治疗完成后 2 周及 3、6、9 和 12 个月进行随访。根据临床总体改善量表(整体 IBS 症状改善)和 IBS 症状严重程度量表(IBS-SSS)来评估治疗反应。

结果:MC-CBT 患者在治疗后每隔三个月进行一次随访,CGI 评分的改善情况基本保持稳定,且下降幅度可以忽略不计。对于 MC-CBT 和 S-CBT,39%和 33%的患者在每次随访中均保持治疗反应,而 EDU 组的这一比例为 19%,显著低于 CBT 组(p<0.05)。在 IBS-SSS 上,治疗效果也呈现出保持的趋势,所有条件下的疗效均随时间推移而增加,在基线和随访之间的平均单位减少约为 -76,在 12 个月时约为 -94(-50 表示具有临床意义)。

结论:对于治疗抵抗的 IBS 患者,家庭和诊所为基础的 CBT 可显著持久地缓解多种 IBS 症状,且这种缓解效果通常可以持续到治疗后 12 个月。

相似文献

[1]
Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.

Am J Gastroenterol. 2019-2

[2]
Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.

Gastroenterology. 2018-4-25

[3]
Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.

Lancet Gastroenterol Hepatol. 2019-9-3

[4]
Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome.

J Consult Clin Psychol. 2021-5

[5]
Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.

Health Technol Assess. 2006-6

[6]
Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility.

Clin Gastroenterol Hepatol. 2008-8

[7]
Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome.

Clin Gastroenterol Hepatol. 2010-2-17

[8]
Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.

Gut. 2019-4-10

[9]
Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome.

Clin Gastroenterol Hepatol. 2018-10-26

[10]
A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome.

Neurogastroenterol Motil. 2021-11

引用本文的文献

[1]
2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome.

J Neurogastroenterol Motil. 2025-4-30

[2]
The Role of Virtual Reality in the Management of Irritable Bowel Syndrome.

Curr Gastroenterol Rep. 2024-11

[3]
The Use of Psychotherapy for Refractory Irritable Bowel Syndrome: A Systematic Review.

Cureus. 2024-2-13

[4]
Factors That Predict Magnitude, Timing, and Persistence of Placebo-Like Response in Patients With Irritable Bowel Syndrome.

Gastro Hep Adv. 2024

[5]
Cognitive Behavioral Therapy for Chronic Pelvic Pain: What Is It and Does It Work?

J Urol. 2024-4

[6]
Gut liver brain axis in diseases: the implications for therapeutic interventions.

Signal Transduct Target Ther. 2023-12-6

[7]
A cognitive-behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health: Preliminary findings of an open pilot study.

Soc Work Ment Health. 2023

[8]
Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment.

World J Gastroenterol. 2023-7-14

[9]
Parieto-occipital ERP indicators of gut mechanosensation in humans.

Nat Commun. 2023-6-13

[10]
Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis.

Front Public Health. 2022

本文引用的文献

[1]
Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.

Gastroenterology. 2018-4-25

[2]
Irritable Bowel Syndrome.

N Engl J Med. 2017-6-29

[3]
Irritable bowel syndrome.

Nat Rev Dis Primers. 2016-3-24

[4]
American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.

Am J Gastroenterol. 2014-8

[5]
Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.

Clin Gastroenterol Hepatol. 2013-3-21

[6]
The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

Contemp Clin Trials. 2012-7-28

[7]
Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.

Am J Med. 2012-4

[8]
Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors.

Clin Gastroenterol Hepatol. 2011-6-21

[9]
Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial.

Am J Gastroenterol. 2011-5-3

[10]
Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome.

Clin Gastroenterol Hepatol. 2010-2-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索